LKC Technologies, Inc. Announces the Availability of Integrated Normative Data on its RETevalŪ Device

Thursday, October 5, 2017 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

Clinical Trial Provides Enhanced Normative Data for the RETeval Device

GAITHERSBURG, Md., Oct. 5, 2017 /PRNewswire/ -- LKC Technologies is announcing that the revolutionary RETeval

device's latest software release (2.8.0) includes age-adjusted normative data, which is available for human use. The reference intervals come from an ongoing clinical trial, the RETeval All Comers Trial (REACT), sponsored by LKC Technologies.

"This is the largest normative data study that LKC has ever conducted, and we are thankful that our customers have partnered with us to gather this critical patient data," said LKC Technologies President James Datovech. "With normative data integrated into the RETeval device, the physician now has valuable input to aid in their interpretation and assessment of test results on a patient. This makes the device even easier to integrate into the practice or clinic, and makes it efficient and intuitive to administer full function ERG tests, while requiring minimal – if any – changes to workflow."

To date, the REACT study has conducted tests in five locations in three states utilizing an IRB approved protocol. All subjects completed informed consent forms. Other statistics include:

  • 522 subjects
  • Age range of 2-93
  • 244 subjects (aged 4- 85) classified as having normal vision
  • Dilated and undilated normal subjects

"The handheld and portable nature of the device made it easy to bring to multiple office locations," said Retinal Specialist Robert Feig, MD of Brooklyn Eye Center. "We were able to test many patients at once, and gathering information was seamless for our technicians and patients. We have been able to see more patients and get better information on their retina function since acquiring the RETeval device last year. Our patient profile is improved since we are bridging the gap between structural and functional information, allowing us to see a full picture of eye health."

To learn more about the FDA cleared RETeval device or other products, visit www.lkc.com/reteval, email [email protected] or call +1 301.840.1992. For information on the clinical trial, visit clinicaltrials.gov and search for NCT03065881 or contact [email protected].

ABOUT LKC TECHNOLOGIESWhen vision issues impact your everyday life, LKC Technologies is here to help. Building on over 40 years of experience in the visual electrophysiology field, the RETevalŪ device is transforming the industry for adults and children alike. Offering full flash ERG and VEP testing to gather objective information on retina function, the RETeval device brings comprehensive electrophysiology technology to any office or clinical setting. LKC Technologies is committed to developing innovative products that lead to the preservation and treatment of sight. LKC Technologies: Vision Defined™. Visit www.LKC.com for more. RETeval is a registered trademark of LKC Technologies.

Contact:Larissa FairLKC [email protected]  301.840.1992

 

View original content:http://www.prnewswire.com/news-releases/lkc-technologies-inc-announces-the-availability-of-integrated-normative-data-on-its-reteval-device-300531642.html

SOURCE LKC Technologies



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store